Research and Markets (http://www.researchandmarkets.com/research/c1f507/business_developme) has announced the addition of the "Business Development: Accelerating the Deal" report to their offering.
Source: Cutting Edge Information
Close key deals and build a top-flight business development team in this report from Cutting Edge Information:
Deal-making is an established strategy for filling company pipelines, raising cash, expanding portfolios and driving long-term revenue. Whether companies forge straightforward licensing agreements or long-term alliances, organizations across the industry depend on other firms’ discovery, development and marketing capabilities to reach a range of different objectives.
Use this report to perfect your team's approach to different elements of the deal-making process. Explore primary data and read other executives' perspectives for a comprehensive look at current business development challenges:
- Align deal making with company and therapeutic franchise strategies
- Win competitive funding and staffing
- Streamline due diligence, early deal evaluation and negotiation
- Build cross-functional excitement for new deals
- Identify red flags and watch for stumbling blocks to deal success
Key Topics Covered:
- Profiled Companies
- Methodology and Definitions
- Business Development: Five Principles for Success
- Opportunity Identification and Evaluation
- Best Practices
- The Deal Identification and Evaluation Process
- Due Diligence
- Goals and Investments
- Cooperation in Due Diligence
- Cross-Functional Involvement
- Best Practices
- Deal Negotiation and Finalization
- Business Development Deal Profiles
- List of Figures
Companies Mentioned:
- Abbott Labs
- Ablynx
- ADVENTRX Pharmaceuticals
- Allergan
- Altus
- Amgen
- Amylin
- AstraZeneca
- Bayer Schering
- Biogen Idec
- Boehringer-Ingelheim
- Bristol-Myers Squibb
- Caprion Proteomics
- Celgene
- Cancer Research Technology
- Compugen
- CytRx
- DSM
- Eisai
- Eli Lilly
- Epix
- Eurand
- Genentech
- GlaxoSmithKline
- Implicit Bioscience
- Janssen-Cilag
- King Pharmaceuticals
- Lexicon
- MedImmune
- Merck & Co.
- Merck Serono
- Nerviano Medical Sciences
- Neurochem
- Neurogen
- Novartis
- Novo Nordisk
- NPS
- Onyx
- Pfizer
- Primus
- Procter & Gamble
- Purdue Pharma
- Roche
- Sanofi-Aventis
- Solvay
- Valeant Canada
- Vifor
For more information visit http://www.researchandmarkets.com/research/c1f507/business_developme
Contacts:
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax
from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
